206.71
price up icon0.00%   +0.00
after-market  After Hours:  206.71 
loading
Teleflex Incorporated stock is currently priced at $206.71, with a 24-hour trading volume of 394.56K. It has seen a +0.00% increased in the last 24 hours and a -4.47% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $207.2 pivot point. If it approaches the $204.9 support level, significant changes may occur.
Previous Close:
$206.71
Open:
$206.84
24h Volume:
394.56K
Market Cap:
$9.74B
Revenue:
$2.97B
Net Income/Loss:
$356.33M
P/E Ratio:
24.23
EPS:
8.53
Net Cash Flow:
$419.20M
1W Performance:
+0.07%
1M Performance:
-4.47%
6M Performance:
+14.24%
1Y Performance:
-22.20%
1D Range:
Value
$206.36
$208.56
52W Range:
Value
$177.63
$276.43

Teleflex Incorporated Stock (TFX) Company Profile

Name
Name
Teleflex Incorporated
Name
Phone
610-225-6800
Name
Address
550 East Swedesford Road, Suite 400, Wayne, PA
Name
Employee
14,400
Name
Twitter
@teleflexinc
Name
Next Earnings Date
2024-05-03
Name
Latest SEC Filings
Name
TFX's Discussions on Twitter

Teleflex Incorporated Stock (TFX) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-04-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-21-23 Downgrade Needham Buy → Hold
May-30-23 Initiated CL King Buy
May-30-23 Resumed Morgan Stanley Equal-Weight
Apr-26-23 Downgrade Wolfe Research Outperform → Peer Perform
Oct-26-22 Initiated Mizuho Neutral
Oct-14-22 Resumed Stephens Overweight
Oct-12-22 Initiated Jefferies Hold
Jul-29-22 Downgrade Wells Fargo Overweight → Equal Weight
Jul-06-22 Initiated Wolfe Research Outperform
May-09-22 Initiated BofA Securities Neutral
Apr-13-22 Initiated Truist Hold
Jan-07-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-04-22 Downgrade Piper Sandler Overweight → Neutral
Dec-10-21 Initiated RBC Capital Mkts Outperform
Oct-07-21 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Sep-07-21 Resumed Raymond James Outperform
Jul-19-21 Downgrade SVB Leerink Outperform → Mkt Perform
Jan-06-21 Reiterated Needham Buy
Nov-02-20 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jan-31-20 Reiterated Needham Buy
Aug-02-19 Reiterated Needham Buy
Jun-11-19 Initiated Wells Fargo Outperform
Apr-24-19 Downgrade Needham Strong Buy → Buy
Feb-22-19 Reiterated Needham Strong Buy
Oct-16-18 Initiated Barclays Equal Weight
Sep-10-18 Upgrade Needham Buy → Strong Buy
Aug-03-18 Reiterated Needham Buy
May-14-18 Reiterated Needham Buy
May-04-18 Reiterated Needham Buy
Apr-04-18 Initiated Goldman Neutral
Nov-10-17 Resumed Piper Jaffray Overweight
Nov-03-17 Reiterated Needham Buy
Sep-08-17 Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-17 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-06-17 Reiterated Needham Buy
Mar-07-17 Initiated Needham Buy
Jan-06-17 Upgrade Jefferies Hold → Buy
Jul-12-16 Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
View All

Teleflex Incorporated Stock (TFX) Financials Data

Teleflex Incorporated (TFX) Revenue 2024

TFX reported a revenue (TTM) of $2.97 billion for the quarter ending December 31, 2023, a +6.57% rise year-over-year.
loading

Teleflex Incorporated (TFX) Net Income 2024

TFX net income (TTM) was $356.33 million for the quarter ending December 31, 2023, a -1.88% decrease year-over-year.
loading

Teleflex Incorporated (TFX) Cash Flow 2024

TFX recorded a free cash flow (TTM) of $419.20 million for the quarter ending December 31, 2023, a +59.42% increase year-over-year.
loading

Teleflex Incorporated (TFX) Earnings per Share 2024

TFX earnings per share (TTM) was $7.53 for the quarter ending December 31, 2023, a -1.95% decline year-over-year.
loading
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.
medical_instruments_supplies ATR
$143.33
price up icon 2.25%
medical_instruments_supplies COO
$88.84
price down icon 1.21%
$75.98
price up icon 0.36%
medical_instruments_supplies BAX
$40.13
price down icon 0.25%
medical_instruments_supplies WST
$360.43
price down icon 2.10%
Cap:     |  Volume (24h):